A 3-Year-Old Girl With Recent Onset of Seizures and Asymmetric Hypermetabolic Activity on 18F-FDG PET/CT.
Journal
Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109
Informations de publication
Date de publication:
01 06 2021
01 06 2021
Historique:
pubmed:
23
4
2021
medline:
21
5
2021
entrez:
22
4
2021
Statut:
ppublish
Résumé
A 3-year-old, previously healthy girl started having clusters of seizures, not responsive to multiple antiepileptic medications. High-dose prednisone and intravenous immunoglobulin could partially control the seizures. Lumbar puncture and CT were normal. An MRI showed right hemispheric injury and atrophy compatible with clinical suspicion of Rasmussen encephalitis. Neurological 18F-FDG PET/CT demonstrated asymmetric hypermetabolic activity in the right frontal and parietal lobes compatible with active inflammation. The patient underwent a right functional hemispherectomy, which confirmed clinical suspicion of Rasmussen encephalitis. During the follow-up, the patient has continued to take phenobarbital and levetiracetam (Keppra), with no recurrence of seizures.
Identifiants
pubmed: 33883487
doi: 10.1097/RLU.0000000000003659
pii: 00003072-202106000-00030
doi:
Substances chimiques
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e325-e326Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: none declared.
Références
Varadkar S, Bien CG, Kruse CA, et al. Rasmussen’s encephalitis: clinical features, pathobiology, and treatment advances. Lancet Neurol . 2014;13:195–205.
Pradeep K, Sinha S, Saini J, et al. Evolution of MRI changes in Rasmussen’s encephalitis. Acta Neurol Scand . 2014;130:253–259.
Granata T, Andermann F. Chapter 54—Rasmussen encephalitis. In: Dulac O, Lassonde M, Sarnat HB, eds. Handbook of Clinical Neurology [Internet] . Elsevier; 2013:511–519. Cited 2020. Available at: http://www.sciencedirect.com/science/article/pii/B9780444528919000543 .
Gilani A, Kleinschmidt-DeMasters BK. How frequent is double pathology in Rasmussen encephalitis? Clin Neuropathol . 2020;39:55–63.
Harris WB, Phillips HW, Chen JS, et al. Seizure outcomes in children with Rasmussen’s encephalitis undergoing resective or hemispheric epilepsy surgery: an individual participant data meta-analysis. J Neurosurg Pediatr . 2019;1–10.
Dupont S, Gales A, Sammey S, et al. Late-onset Rasmussen encephalitis: a literature appraisal. Autoimmun Rev . 2017;16:803–810.
Britton J. Chapter 13 - Autoimmune epilepsy. In: Pittock SJ, Vincent A, eds. Handbook of Clinical Neurology [Internet] . Elsevier; 2016:219–245. cited 2020. Available at: http://www.sciencedirect.com/science/article/pii/B978044463432000013X .
Fiorella DJ, Provenzale JM, Coleman RE, et al. 18 F-fluorodeoxyglucose positron emission tomography and MR imaging findings in Rasmussen encephalitis. Am J Neuroradiol . 2001;22:1291–1299.
Bien CG, Granata T, Antozzi C, et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain . 2005;128:454–471.
Geller E, Faerber EN, Legido A, et al. Rasmussen encephalitis: complementary role of multitechnique neuroimaging. AJNR Am J Neuroradiol . 1998;19:445–449.
Morbelli S, Djekidel M, Hesse S, et al. Role of (18)F-FDG-PET imaging in the diagnosis of autoimmune encephalitis. Lancet Neurol . 2016;15:1009–1010.